×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
COGT – cogent biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
COGT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/3
09:41 pm
cogt
A Look At Cogent Biosciences (COGT) Valuation After Recent Share Price Volatility [Yahoo! Finance]
Neutral
Report
A Look At Cogent Biosciences (COGT) Valuation After Recent Share Price Volatility [Yahoo! Finance]
3/3
07:03 pm
cogt
Bezuclastinib SUMMIT Data Reframe Cogent Biosciences Mastocytosis Opportunity [Yahoo! Finance]
Neutral
Report
Bezuclastinib SUMMIT Data Reframe Cogent Biosciences Mastocytosis Opportunity [Yahoo! Finance]
3/2
03:12 am
cogt
Cogent Biosciences Inc. (COGT) Set for Bezuclastinib Launch, Awaiting FDA Approval [Yahoo! Finance]
Low
Report
Cogent Biosciences Inc. (COGT) Set for Bezuclastinib Launch, Awaiting FDA Approval [Yahoo! Finance]
2/28
10:13 am
cogt
Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting [Yahoo! Finance]
Low
Report
Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting [Yahoo! Finance]
2/28
09:45 am
cogt
Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting
Low
Report
Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting
2/27
04:15 pm
cogt
Analyst Bullish on Cogent (COGT) Amid Expected Drug Approval [Yahoo! Finance]
Low
Report
Analyst Bullish on Cogent (COGT) Amid Expected Drug Approval [Yahoo! Finance]
2/19
11:11 am
cogt
Cogent Biosciences (NASDAQ:COGT) was given a new $35.00 price target on by analysts at Robert W. Baird.
Low
Report
Cogent Biosciences (NASDAQ:COGT) was given a new $35.00 price target on by analysts at Robert W. Baird.
2/18
07:18 am
cogt
Cogent Biosciences (NASDAQ:COGT) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Cogent Biosciences (NASDAQ:COGT) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/17
04:43 pm
cogt
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Commodore Capital LP
Low
Report
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Commodore Capital LP
2/17
04:04 pm
cogt
Form S-8 Cogent Biosciences, Inc.
Low
Report
Form S-8 Cogent Biosciences, Inc.
2/17
12:43 pm
cogt
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Kynam Capital Management, LP
Low
Report
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Kynam Capital Management, LP
2/17
09:25 am
cogt
Form 10-K Cogent Biosciences, Inc. For: Dec 31
Medium
Report
Form 10-K Cogent Biosciences, Inc. For: Dec 31
2/17
08:12 am
cogt
Form 8-K Cogent Biosciences, Inc. For: Feb 17
Low
Report
Form 8-K Cogent Biosciences, Inc. For: Feb 17
1/30
01:27 pm
cogt
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: VANGUARD GROUP INC
1/22
08:10 pm
cogt
Form 4 Cogent Biosciences, Inc. For: Jan 22 Filed by: Fairmount Funds Management LLC
Medium
Report
Form 4 Cogent Biosciences, Inc. For: Jan 22 Filed by: Fairmount Funds Management LLC
1/22
08:05 pm
cogt
Form 144 Cogent Biosciences, Inc. Filed by: Fairmount Funds Management LLC
Medium
Report
Form 144 Cogent Biosciences, Inc. Filed by: Fairmount Funds Management LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: